The authors confirm that all data underlying the findings are fully available without restriction. Data have been deposited to OpenfMRI and are available at: <https://openfmri.org/dataset/ds000133>.

Introduction {#s1}
============

Modafinil is a compound employed in the treatment of sleep disorders, and, off-label, also used for the treatment of cognitive deficits in schizophrenia, Attention Deficit/Hyperactivity Disorder (ADHD), and mood disorders [@pone.0107145-Kahbazi1]--[@pone.0107145-Nasr1]. Previous preclinical and human studies have indicated that modafinil modulates neurotransmission in several brain regions including the hypothalamus, hippocampus, basal ganglia and prefrontal regions. The compound acts on orexin, monoamines and dopamine as well as on glutamate, and gamma-aminobutyric acid [@pone.0107145-Wisor1]--[@pone.0107145-Volkow1]. Recent studies have indicated that modafinil positively modulates attention, memory, and executive functions [@pone.0107145-Turner1], [@pone.0107145-Minzenberg2]. Modafinil can be considered a cognitive enhancer that, compared to amphetamine-like psychostimulants, may have lower risks of inducing addiction [@pone.0107145-Moldofsky1]--[@pone.0107145-Ghahremani1].

In a previous study, we have reported that the administration of a single dose (100 mg) of modafinil affects the brain resting state network (RSN) activity in healthy young individuals [@pone.0107145-Esposito1]. The study showed that, of six selected RSNs \[the Default Mode Network, the Salience Network (SN), the Fronto Parietal Control network (FPC; lateralized in both hemispheres), the Sensory Motor Network, the Exstrastriate Visual System and the Dorsal Attention Network (DAN)\], functional connectivity (FC) effects were found only in the FPC and DAN. No statistically significant modifications were observed in the SN.

The SN is composed of three nodes. The SN includes the bilateral insular cortices and dorsal anterior cingulate cortex as well as subcortical structures like the amygdala, the substantia nigra/ventral tegmental area, and the thalamus [@pone.0107145-Seeley1]. The SN plays an important role in controlling attention toward biologically-relevant and cognitively-relevant stimuli present in the environment [@pone.0107145-Seeley1], [@pone.0107145-Menon1], an overall function that helps to guide behavior.

Several imaging studies have shown that the insula and cingulate cortex are simultaneously activated upon cognitive tasks [@pone.0107145-Taylor1]. The insula is indeed considered a critical hub that mediates the information flow within the SN [@pone.0107145-Seeley1], [@pone.0107145-Menon1]. The region interacts with limbic, somatosensory, and motor regions and is also crucial in the coordination of sensorimotor, visceral, and interoceptive processing as well as in controlling homeostatic/allostatic functions like self-awareness and empathy [@pone.0107145-Craig1]--[@pone.0107145-Seminowicz1]. The insula is also critical in controlling motivation, a process that is partly mediated by the activation of the orexin receptor, a preferential pharmacological target for modafinil [@pone.0107145-Hollander1]. In summary, functioning of the insula is important in the response to salient environmental stimuli as the region promotes a spatio-temporal integration that is needed for cognitive and emotional elaborations [@pone.0107145-Menon1].

Several studies have shown functional sub-differentiations within the insular cortex when considering the activity of the anterior versus posterior portions of the region. The anterior part appears to be mainly involved in cognitive and socio-cognitive functions such as empathy processing, emotional salience detection, and attentional control [@pone.0107145-Seeley1]; [@pone.0107145-Corbetta1]--[@pone.0107145-Fox1]. The posterior part modulates sensorimotor tasks [@pone.0107145-Karnath1]. These different functions are matched by distinct connectivity patterns between the two subregions and other brain areas. The anterior insula is functionally connected with the Anterior Cingulate Cortex (ACC) whereas the posterior insula appears to be mainly connected with the somatosensory and middle cingulate cortices [@pone.0107145-Menon1], [@pone.0107145-Taylor1], [@pone.0107145-Cauda1].

In a previous study, we have observed that healthy young individuals, after modafinil administration, showed improvement in fluid reasoning as measured with Advanced Progressive Matrices (APM) [@pone.0107145-Esposito1], [@pone.0107145-Raven1]. Previous imaging studies have indicated that SN nodes, i.e.: bilateral insulae and the cingulate cortex are involved in tasks set to stimulate fluid reasoning [@pone.0107145-Perfetti1], [@pone.0107145-Yuan1] but in our study were unable to detect significant modafinil effects on SN activation [@pone.0107145-Esposito1]. In the past decade, resting state fMRI (rs-fMRI) has emerged as valuable tool for the study of neural activity when the brain is at rest and not involved in task completion. Compared to task-related fMRI, rs-fMRI offers the advantage of allowing the investigation of simultaneous and coordinated activity of multiple and well-defined brain networks. This approach also reduces confounding factors like the inter-individual variability in task compliance and/or performance that can occur upon fMRI acquisition [@pone.0107145-Esposito1]. rs-fMRI has been successfully employed to evaluate FC modifications [@pone.0107145-VanDenHeuvel1]. FC is studied with MRI through the analysis of simultaneous variations of BOLD (Blood-Oxygen-Level-Dependent) signals occurring in distinct brain regions [@pone.0107145-Fox1], [@pone.0107145-Biswal1], [@pone.0107145-Horwitz1]. FC can be studied at rest by evaluating spontaneous low frequency fluctuations of BOLD signals in different brain voxels. The process allows the identification of temporally-related patterns of activity across brain regions that are involved in similar or related functions [@pone.0107145-Birn1].

Given the subregional differentiation of the insular cortex and its role in the SN, we have decided to re-analyze our fMRI data with the aim of exploring modafinil-induced subregional patterns of FC that is occurring within the insulae as these insular subregions are central for the beneficial cognitive effects we have observed after a single dose exposure to the drug [@pone.0107145-Esposito1].

To that aim, fMRI acquisitions obtained in the previous study were now analyzed with a seed-based approach that was focused only on activity occurring in the left and right insulae divided in anterior and posterior subregions.

Materials and Methods {#s2}
=====================

Ethics Statement {#s2a}
----------------

The protocol for this trial and supporting CONSORT checklist are available as supporting information; see [Checklist S1](#pone.0107145.s001){ref-type="supplementary-material"} and [Protocol S1](#pone.0107145.s002){ref-type="supplementary-material"}.

The study was approved by the ethics committee of University of Chieti (PROT 2008/09 COET on 14/10/2009) and conducted in accordance with the Helsinki Declaration.

The study design was explained in detail and written informed consent was obtained from all participants involved in our study. Recruitment was performed throughout February 2011, drug/placebo administration and fMRI acquisitions started on March 2011, went on until January 2102, and the study was completed with the last fMRI session in January 2012. After securing financial coverage for costs related to the analysis of the study, the trial was registered on 10/09/2012 (ClinicalTrials.gov NCT01684306 <http://clinicaltrials.gov/ct2/show/NCT01684306>). After obtaining registration, the double blind study was opened and analyzed, rs-fMRI data were investigated by means of independent component analysis (ICA) leading to a first publication of the dataset[@pone.0107145-Esposito1]. The protocol is the same as the previous study [@pone.0107145-Esposito1] with no deviations made. The authors confirm that all ongoing and related trials for these drug/interventions are registered.

Study group, design, and rs-fMRI acquisition {#s2b}
--------------------------------------------

The study group, experimental design, and rs-fMRI data acquisition are described in the original study \[14; [Figure 1](#pone-0107145-g001){ref-type="fig"}\]. Randomization of study subjects was obtained by means of random number generator. In our study, in line with similar pharmacological-fMRI studies, and also considering that we did not have preliminary data that could be used to, a priori, estimate the optimal sample size, we have evaluated two groups of 13 subjects that is nowadays an accepted size in these kind of studies.

![CONSORT Diagram.\
Flow diagram graphically describes the design of the study: enrollment, intervention, follow-up and data analysis.](pone.0107145.g001){#pone-0107145-g001}

MRI/fMRI data analysis {#s2c}
----------------------

MRI and fMRI data were analyzed with the Brain Voyager QX 2.3 software (Brain Innovation, Maastricht, The Netherlands). Preprocessing of functional data was performed by sequentially applying slice scan time correction, three-dimensional motion correction, and removal of linear trends from voxel time series. Preprocessed functional volumes were then co-registered with the corresponding structural dataset. Both structural and functional volumes were then transformed into the Talairach space [@pone.0107145-Talairach1] using a piecewise affine and continuous transformation. Functional volumes were re-sampled at a voxel size of 3×3×3 mm^3^. A spatial smoothing with a Gaussian kernel of 6.0 mm full-width half-maximum was applied to functional images corresponding to two voxels in the re-sampled data to account for intersubject variability while maintaining a relatively high spatial resolution.

FC analysis {#s2d}
-----------

Previous studies have identified different subregions in the insular cortices in both humans and non-human primates [@pone.0107145-Augustine1]. These subregions appear to show different connectivity patterns with remaining brain regions. To examine FC patterns in the insular cortices, four ROIs were selected for each subject, before and after drug/placebo administrations, within the anterior portion of the left hemisphere (AIlh) or right hemisphere (AIrh) and posterior portions of the left (PIlh) or right hemisphere (PIrh). Regions of interest (ROIs) were determined using Talairach coordinates. Talairach coordinates are defined on the basis of two brain structures: the anterior and posterior commissures. Distances in Talairach coordinates are measured from the anterior commissure that is, by convention, intended as the origin [@pone.0107145-Talairach1]. The y-axis represents the anterior

-\>posterior direction, the x-axis represents the left-\>right, and the z-axis is depicts the dorsal-\>ventral direction ([Table 1](#pone-0107145-t001){ref-type="table"}, [@pone.0107145-Talairach1]). Each ROI was created by means of TalCoord2VOI plug-in with a radius of 2,5 mm to avoid White Matter (WM) inclusions.

10.1371/journal.pone.0107145.t001

###### Between-group comparison for right posterior insula for the contrast T1\>T0.

![](pone.0107145.t001){#pone-0107145-t001-1}

  Cluster                              BA      Hemisphere     X       Y      Z     Nr. Voxels
  -------------------------------- ---------- ------------ ------- ------- ------ ------------
  SFG                                  6           R        55.3    −4.1    23.1       60
  MTG                                  22          R        46.9    −407.   15.8      1053
  Putamen                                          R        27.8      9     1.1       197
  Precuneus                          29/30         R        18.1    −55.9   28.5      159
  ACC                                  24          R        10.2     −20    31.5      317
  SFG                                  6           R         0.6    −13.9   55.4      2643
  dorsal PCC                           31          R         2.7     −20    37.9      137
  ACC                                  24          L        −12.7   −2.9    31.7      855
  Putamen                                          L        −22.8     1     −4.7      118
  Posterior Insula/temporal pole    13/38/34       L        −45.4    −4     −0.1      2836
  Anterior prefrontal cortex           10          L        −33.2   26.9    20.2       68

Table indicates brain regions showing significant differences when considering T1 (drug \>placebo)\>T0 (drug\>placebo) for the right Posterior Insula (PIrh). Brain regions are listed with the mean Talairach coordinates (x: left-right; y: anterior-posterior; z: dorsal ventral) and the corresponding number of voxels.

Abbreviations: BA: Brodmann\'s area; L: left; R: right. PCC: Posterior Cingulate Cortex; MTG: Middle Temporal gyrus; ACC: Anterior Cingulate cortex; SFG: Superior Frontal gyrus.

Whole brain seed-based connectivity maps, related to the selected ROIs (see above), were created for all subjects. We then calculated correlations between ROI time-courses (i.e.: the time-course in each of the insula subregions) and all the time-courses of the brain voxels [@pone.0107145-Fox2]. BOLD time-courses were extracted from each ROI by obtaining an average value for each voxel of the ROI modeled for each single subject. To reveal FC patterns that were consistent for the groups along with the T0 and T1 time points in relation to each insular subregions, we proceeded in the following way: after applying the Fisher\'s r-to-z transformation to each correlation map, random-effect analysis was independently performed for each of the two study groups and the two acquisition time points.

FC maps were computed according to Margulies et al. [@pone.0107145-Margulies1]. Nuisance covariates were included in the analyses to reduce effects of physiological processes such as fluctuations related to cardiac and respiratory cycles [@pone.0107145-Bandettini1], [@pone.0107145-Napadow1] or to motion. To this aim, we included eight additional covariates that modeled nuisance signals sampled from WM and Cerebro-Spinal Fluid (CSF) [@pone.0107145-Weissenbacher1], as well as from six motion parameters (3 rotations and 3 translations as saved by the 3D motion correction). We derived WM/CSF nuisance signals averaging voxel time courses in each subject whole brain WM/CSF masks. These masks were generated by the segmentation process of each subject brain by means of Brain voyager QX. All seed-based predictors were z-normalized and analyses repeated with each insular subdivision inserted in a separate regression model.

Statistical analysis {#s2e}
--------------------

For each seed ROI, subject, and condition (drug vs. placebo), and time (T0 vs. T1), a FC map was computed on a voxel-wise basis. For each subject, the general linear model (GLM) [@pone.0107145-Friston1] for multiple regression analysis produced four ROI-based t-maps. To assess group differences between T0 and T1, four different voxel-wise mixed model Analyses of Variances were performed by means of the ANOVA tool of Brain Voyager QX set with one between-group factor (drug vs. placebo) and a repeated measure factor (T1 vs. T0). To control for absence of between-group differences, a between-group comparison was performed at T0. To assess effect of drug/placebo network FC of each ROI, we performed the contrast T1 (drug\>placebo)\> T0 (drug\>placebo). Statistical significance was assessed by setting a threshold that was corrected by the False Discovery Rate (FDR) \[q\<0.02 corresponding to t\>3.93 and p\<0.001 at voxel level; 42\]. To avoid circularity effects, statistical analyses were performed in accordance with what indicated by Kriegerskorte and colleagues [@pone.0107145-Kriegeskorte1].

Results {#s3}
=======

Four patterns of ROI seed-based FC patterns were investigated in specific insular subdivisions. The analysis was performed on rs-FMRI data at T0 (before the administration of drug/placebo) and T1 (after the administration of drug/placebo). FC maps were calculated for each seed ROI \[Anterior Insula left hemisphere (AIlh); Anterior Insula right hemisphere (AIrh); Posterior Insula left hemisphere (PIlh); Posterior Insula right hemisphere (PIrh)\] and showed distinct patterns of connectivity in specific insular subregions. Resulting maps were corrected for multiple comparisons by means of Bonferroni correction with a threshold set at p\<0.05 ([Figure 2](#pone-0107145-g002){ref-type="fig"} and [3](#pone-0107145-g003){ref-type="fig"}, [Table 2](#pone-0107145-t002){ref-type="table"}). At T0, no differences were found in the two groups as far as FC of the four insular subregions with a p\<0.02 FDR corrected ([Figure 4](#pone-0107145-g004){ref-type="fig"}).

![Insula functional connectivity patterns before drug/placebo treatment.\
Image depicts functional connectivity patterns of the four subregions of bilateral insulae as assessed with rs-fMRI. Maps are overimposed on a Talairach atlas and in radiological convention with a statistical significance set at p\<0.05 Bonferroni corrected. AIlh = anterior insula left hemisphere; AIrh  = anterior insula right hemphere; Pilh = posterior insula left hemisphere; PIrh =  posterior insula right hemisphere.](pone.0107145.g002){#pone-0107145-g002}

![Between-group comparison of the right posterior insula pattern before and after drug/placebo treatment.\
Image depicts the map obtained after contrast T1 (drug\>placebo) \>T0 (drug\>placebo) for the right posterior insula (PIrh). The map is overimposed on a Talairach atlas and in radiological convention (p\<0.02 FDR corrected). Differences are assessed by means of a mixed model voxel wise ANOVA with a between-group factor (Drug vs Placebo) and a repeated measure factor (T0 vs. T1).](pone.0107145.g003){#pone-0107145-g003}

![Between-group comparison of the four insula subregions before drug/placebo treatment.\
Image depicts maps obtained after contrast T0 (Drug\>Placebo) for the four subregions of bilateral insulae as assessed with rs-fMRI. Maps are overimposed on a Talairach atlas and in radiological convention (p\<0.02 FDR corrected). Differences are assessed by means of a mixed model voxel wise ANOVA with a between-group factor (Drug vs Placebo) and a repeated measure factor (T0 vs. T1) and specific contrast T0 (Drug\>Placebo). AIlh = anterior insula left hemisphere; AIrh = anterior insula right hemphere; Pilh = posterior insula left hemisphere; PIrh = posterior insula right hemisphere.](pone.0107145.g004){#pone-0107145-g004}

10.1371/journal.pone.0107145.t002

###### Insula subregional seed-based correlation.

![](pone.0107145.t002){#pone-0107145-t002-2}

  Anterior insula - Left hemisphere               Seed: x = −38; y = 15; z = −2                              
  ---------------------------------------------- ------------------------------- --- ------- ------- ------- -------
  **T0 -Drug**                                                                                               
  Insula IFG pars opercularis and triangularis              13/44/45                                         
  STG putamen                                                /22/41               R   43.2    −6.7     5.9    44739
  Parahippocampus temporal pole amygdala                                          R   30.9    −28.2   −20.5    186
  Retrosplenial PCC                                           29/31               L   −0.2    −39.1    9.1    8517
  Ventral and dorsal ACC premotor cortex                     24/32/6              R    11      0.2    40.8    10995
  Insula IFG pars opercularis and triangularis              13/44/45                                         
  STG putamen                                                /22/41               L   −41.3    0.5     2.6    49422
  **T0 - Placebo**                                                                                           
  Insula IFG pars opercularis and triangularis              13/22/44                                         
  STGputamen                                                 /45/41               R   41.8    −1.9      6     42945
  Retrosplenial PCC                                         23/29/31              R    4.5    −47.8   11.1    29163
  Parahippocampus temporal pole amygdala                       38                 R   30.1    −24.5   −16.5   1091
  MFG                                                           8                 R   20.7    16.7    43.3     685
  Ventral and dorsal ACC premotor cortex                     32/24/6              L   −0.1     1.2    39.4    13217
  Insula IFG pars opercularis and triangularis              13/22/44                                         
  STG putamen                                                /45/41               L   −42.5   −0.9     3.5    47833
  Dorsolateral preforntal cortex                                9                 L   −31.5   36.2    24.4     284
  **T1 - Drug**                                                                                              
  Insula IFG pars opercularis and triangularis                                                               
  STG putamen                                              44/47/13/40            R   43.9    −7.7     7.9    51049
  Retrosplenial PCC                                         30/31/23              R    4.2    −47.2   13.5    28483
  Parahippocampus temporal pole amygdala                       38                 R   30.5    −26.8   −19.1    334
  Extra striate cortex                                         18                 R   23.8    −78.5   −18.5    523
  Cudate Nucleus                                                                  R   20.8    −12.9   25.5     496
  Ventral and dorsal ACC premotor cortex                     6/24/32              R     0     −2.7    40.6    16971
  MFG                                                           8                 L   −13.1   31.9     40      65
  Insula IFG pars opercularis and triangularis              13/45/44                                         
  STGputamen                                                /41/42/22             L   −44.4   −6.6     4.1    57332
  Augular and supramerginal gyrus                             39/40               L   −42.1    −64    23.3    1865
  **T1 - Placebo**                                                                                           
  Insula IFG pars opercularis and triangularis              44/45/13                                         
  STG putamen                                               /22/40/41             R   43.1    −1.9     6.2    42772
  Retrosplenial PCC                                        30/29/23/31            R    5.4    −46.9   13.2    18684
  Ventral and dorsal ACC premotor cortex                     6/24/32              R    0.5     2.7    38.8    11655
  Insula IFG pars opercularis and triangularis              44/45/13                                         
  STG putamen                                               /22/40/41             L   −42.2   −1.1     3.1    43055

  Anterior insula - Right hemisphere              Seed: x = 37; y = 16; z = 3                              
  ---------------------------------------------- ----------------------------- --- ------- ------- ------- -------
  **T0 - Drug**                                                                                            
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                R   39.8    −2.0     6.6    70971
  Ventral and dorsal ACC                                     32/24              R    3.2     0.3     40     23859
  PCC                                                         30                L   −2.9    −52.5   12.3    5600
  SFG/MFG                                                     6/8               L   −26.7    6.3    42.3    2167
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                L   −43.4   −1.4      2     30606
                                                              39                L   −36.6   −66.9   25.4    5522
  **T0 - Placebo**                                                                                         
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                R   41.1    −3.5     7.9    84229
  Angular and supramarginal gyrus                            39/40              R   42.8    −65.7   18.7    1862
  Ventral and dorsal ACC                                     32/24              R    3.9    −2.9    40.5    24955
  Retrosplenial PCC                                        23/30/31             L   −5.2    −51.2   11.2    24438
  SFG/MFG                                                     6/8               L   −20.3   16.4     45     6172
  Parahippocampus temporal pole amygdala                                        L   −27.8   −17.2   −22.3   1174
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                L   −40.9     2     −0.3    23190
  Angular and Supramarginal gyrus                            39/40              L   −40.6   −66.9   20.1    5946
  SFG premotor cortex                                          6                L   −44.2   10.2    33.6     537
  STG                                                        22/42              L   −60.1   −32.7   16.3    1413
  **T1 - Drug**                                                                                            
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                R   39.5    −0.9     7.7    71046
  Ventral and dorsal ACC                                     32/24              R    1.7     2.6    38.0    24485
  Retrosplenial PCC                                        23/30/31             L   −5.4    −52.2   14.7    7612
  SFG premotor cortex                                          6                L   −21.9   16.8    44.7    2611
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                L    −42    −1.5     1.7    31194
  Angular and supramarginal gyrus                            39/40              L   −40.5   −64.2   23.2    6336
  **T1 - Placebo**                                                                                         
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                R    40      −2      5.3    59401
  Ventral and dorsal ACC                                     32/24              R    1.4     7.4    35.5    16035
  Insula IFG pars opercularis and triangularis           13/22/44/45/4                                     
  STGputamen thalamus                                          1                L   −38.0    3.7    −0.7    23429
  Angular and Supramarginal gyrus                            39/40              L   −41.7   −63.4   20.6     825
  STG                                                        22/42              L   −59.4   −33.5   18.5     382

  Posterior insula -- Left hemisphere                                                    seed: x = −42; y = −9; z = 4                             
  ------------------------------------------------------------------------------------- ------------------------------ --- ------- ------- ------ -------
  **T0 -- Drug**                                                                                                                                  
  Insula IFG pars opercularis and triangularis                                                     13/22/44                                       
  STG putamen                                                                                       /45/41              R   43.9    −8.9    8.8    44235
  ACC                                                                                                 24                L   −0.5    −6.9    37.5   4060
                                                                                                  13/22/44/                                       
  Insula IFG pars opercularis and triangularis pre and post central gyrus STG putamen           45/41/2/4/3/6           L   −44.7    −8     6.7    62929
  **T0 -- Placebo**                                                                                                                               
  Insula IFG pars opercularis and triangularis                                                      13/22/                                        
  STG putamen                                                                                      44/45/41             R   43.7    −7.6    9.3    36180
  PCC SPL                                                                                         23/30/31/7            R     6     −52.4   18.9   33283
  MFG                                                                                                 8                 R    20     23.8    44.5   2378
  ACC                                                                                                 24                L   −1.4    −8.2    38.2   3288
                                                                                                  13/22/44/                                       
  Insula IFG pars opercularis and triangularis pre and post central gyrus STG putamen           45/41/2/4/3/6           L   −43.6   −8.7    7.7    58956
  **T1 -- Drug**                                                                                                                                  
  Insula IFG pars opercularis and triangularis pre and post central gyrus STGputamen        13/22/44/45/41/2/3/3/6      R   44.7    −10.2    11    54610
  PCC SPL                                                                                         23/30/31/7            L   −0.4    −49.8   20.2   22724
  ACC                                                                                                 24                R    0.1    −11.5   42.3   14520
  Insula IFG pars opercularis and triangularis pre and post central gyrus STGputamen        13/22/44/45/41/2/4/3/6      L   −46.5   −9.4    8.2    64141
  Angular gyrus                                                                                       39                L   −43.2   −63.7   22.3    64
  **T1 -- Placebo**                                                                                                                               
  Insula IFG pars opercularis and triangularis                                                    13/22/44/                                       
  STG putamen                                                                                       45/41               R   45.2    −7.9    11.2   42828
  ACC                                                                                                 24                R    0.5    −8.9    42.1   5533
  Insula IFG pars opercularis and triangularis pre and post central gyrus STGputamen        13/22/44/45/41/2/4/3/6      L   −45.5   −11.1   8.3    59758

  Posterior insula - Right hemisphere             seed: x = 39; y = −9; z = 9                             
  ---------------------------------------------- ----------------------------- --- ------- ------- ------ -------
  **T0 - Drug**                                                                                           
  Insula IFG pars opercularis and triangularis             13/22/44/                                      
  STG putamen                                                45/41              R   43.4    −7.6    6.3    55307
  SPL                                                          7                R   18.3    −48.1   51.8    122
  SFG ventral and dorsal ACC                                6/32/24             R    4.8    −10.1   44.6   6387
  PCC                                                      23/30/31             L   −3.9    −44.2   12.2   8458
  Insula IFG pars opercularis and triangularis             13/22/44/                                      
  STG putamen                                                45/41              L   −44.9   −3.7    1.2    26362
  Angular gyrus                                               39                L   −38.7   −65.1   25.5    728
  **T0 - Placebo**                                                                                        
  Insula IFG pars opercularis and triangularis           13/22/24 44/                                     
  ACC STG putamen                                            45/41              R   40.8    −7.6    10.6   91610
  PCC angular gyrus                                        23/30/31             L   −11.1   −46.8   15.4   67270
  Prefrontal cortex                                          8/10               L   −9.7    25.7    40.3   37524
  Angular gyrus                                               39                R   −44.2   −59.6   22.6   3245
  Insula IFG pars opercularis and triangularis             13/22/44/                                      
  STG putamen                                                45/41              L   −46.8   −6.5    0.8    25923
  SPL                                                          7                R   19.7    −52.7   4.8    1229
  **T1 - Drug**                                                                                           
  Insula IFG pars opercularis and triangularis             13/22/44/                                      
  STG putamen                                                45/41              R   43.4    −9.1     10    65731
  ACC SFG pre and postcentral gyrus                       24/6/1/2/3            R    6.8    −19.2   46.2   25291
  PCC                                                      23/30/31             L   −3.2    −51.4    18    24282
  Dorsolateral prefrontal cortex                               9                L   −20.6   22.1    40.9   10736
  Insula IFG pars opercularis and triangularis             13/22/44/                                      
  STG putamen                                                45/41              L   −47.6   −6.7    4.1    29616
  Angular gyrus                                               39                L    −42    −63.7   24.1   5383
  Angular gyrus                                               39                R   45.4    −62.6   23.2    254
  **T1 - Placebo**                                                                                        
  Insula IFG pars opercularis and triangularis       13/22/44/45/41/6/3/4/                                
  STGputamen pre and postcentral gyrus                         2                R   43.9    −8.9    9.7    58139
  SPL                                                          7                R   20.9    −47.1   51.9   1826
  Caudate nucleus                                                               R   13.7    22.2    11.6    436
  SFG ACC                                                    24/6               R    4.8    −15.4   47.8   1741
  Precuneus                                                   29                L   −5.9    −59.8    26    2072
  PCC                                                        23/29              L   −2.5    −36.1   4.2    5523
  MFG                                                          8                L    −12    26.6    46.4   1861
  SPL                                                          7                L   −24.1   −41.7   54.9    321
  Insula IFG pars opercularis and triangularis           13/22/44/45/                                     
  STG putamen                                                 41                L   −46.8   −8.2    1.9    21263
  Angular gyrus                                               39                L    −41    −61.9   23.5   2094

Table indicates brain regions showing seed-based functional connectivity \[with significance level set at P\<0.05 (Bonferroni corrected)\] for the left anterior (AIlh) right anterior (AIRh) left posterior (PIlh) and right posterior (PIrh) at T0 or T1 respectively. Brain regions are listed according to mean Talairach coordinates (x: left-right; y: anterior-posterior; z: dorsal ventral) and corresponding number of voxels.

Abbreviations: BA: Brodmann\'s area; L: left; R: right. PCC: Posterior Cingulate Cortex; MFG: Middle frontal gyrus; STG:Superior Temporal gyrus; IFG: Inferior Frontal gyrus; ACC: Anterior Cingulate cortex; SPL: Superior Parietal Lobe; SFG: Superior Frontal gyrus.

Baseline analysis at T0 confirmed known distinct patterns of connectivity of the four insular subregions. AIlh and AIrh showed significant FC with the ipsilateral inferior frontal gyrus (IFG), the posterior insular cortex, the anterior middle cingulate cortex (aMCC), the ACC, the superior frontal gyrus (SFG), the contralateral anterior and posterior insula. For PIlh and PIrh, FC was found with the putamen bilaterally, the dorsal ACC and the precentral and postcentral gyri as well as with the contralateral anterior and posterior insulae.

At T1, both study groups showed FC maps for AIlh and AIrh that were largely similar to the ones found at T0. AIlh and AIrh showed significant FC with the above listed T0 regions with the addition of the superior temporal gyrus (STG) and the dorsolateral prefrontal cortex (dlPFC). At T1, maps for PIlh and PIrh indicated FC with the contralateral posterior/middle insula, the putamen, the parahyppocampus, the MCC, the precentral/postcentral gyri, and the superior parietal lobule (SPL).

We then performed a comparison of T1 (drug\>placebo) versus T0 (drug\>placebo) for each seed ROI maps setting significance levels at p\<0.02 FDR corrected. AIlh, AIrh and PIlh showed no significant differences. The only significant difference was observed for PIrh. The regions showed, bilaterally, a significant FC increase in the SFG, putamen, and dorsal ACC. A lateralized effect was found in the right hemisphere with significant differences in the middle temporal gyrus whereas significant between-group differences were observed, at T1\>T0, for the left posterior insula and left temporal pole up to the parahippocampal region ([Figure 3](#pone-0107145-g003){ref-type="fig"}, [Table 1](#pone-0107145-t001){ref-type="table"}).

Discussion {#s4}
==========

In the present study, we investigated subregional FC effects of modafinil in the insula. Posterior and anterior insular cortices showed differential functional behavior ([Figure 2](#pone-0107145-g002){ref-type="fig"} and [5](#pone-0107145-g005){ref-type="fig"}, [Table 2](#pone-0107145-t002){ref-type="table"}).

![Insula functional connectivity patterns after drug/placebo treatment.\
Image depicts functional connectivity patterns of the four subregions of bilateral insulae as assessed with rs-fMRI. Maps are overimposed on a Talairach atlas and in radiological convention with a statistical significance of p\<0.05 Bonferroni corrected. AIlh = anterior insula left hemisphere; AIrh = anterior insula right hemphere; Pilh = posterior insula left hemisphere; PIrh = posterior insula right hemisphere.](pone.0107145.g005){#pone-0107145-g005}

In the modafinil group, after drug analysis revealed distinctive FC patterns within nodes of the right posterior insula. After modafinil administration, we found increased FC levels in the putamen, left parahippocampus, left posterior insula and MCC ([Figure 3](#pone-0107145-g003){ref-type="fig"}, [Table 2](#pone-0107145-t002){ref-type="table"}). Our results indicate that the drug does not reorganize FC within sub-regions of the insula but strengthens the region overall connectivity, a phenomenon commonly observed in fMRI studies [@pone.0107145-Chang1].

In a previous study, we have found that a single dose administration of modafinil does not modify SN activity [@pone.0107145-Esposito1]. However, previous findings indicate that the anterior insula, a major SN hub [@pone.0107145-Seeley1], is activated by modafinil in methamphetamine addicts who were undergoing a reversal learning task [@pone.0107145-Ghahremani1]. The anterior insula has also been shown to be involved in tasks focused on modulation of fluid reasoning [@pone.0107145-Perfetti1], another cognitive function that we have found improved in modafinil treated subjects [@pone.0107145-Esposito1].

Seed-based analysis of functioning of insular subregions offered additional information that could help to reconcile these divergent results.

Our within-group results showed patterns of FC occurring between the anterior insula and frontal regions, the ACC, and the controlateral insula. The posterior insula showed FC with the putamen bilaterally, the dorsal ACC, and the precentral and postcentral gyri as well as with the contralateral anterior and posterior insulae. These FC results are in line with known anatomical connections [@pone.0107145-Augustine1].

Previous rs-fMRI studies have shown that the insula is involved in two distinct neural networks. The first network links the anterior insula to the ACC, the prefrontal and frontal cortex as well as to parietal and temporal regions. The second network links the posterior insular cortex to the middle cingulate, sensorimotor, premotor, and temporoparietal cortices. This posterior pattern is mainly involved in motor functions such as body orientation, monitoring of the environment and response selection [@pone.0107145-Taylor1], [@pone.0107145-Craig1]; [@pone.0107145-Flynn1]--[@pone.0107145-Kurth1].

The two networks communicate with a posterior-anterior modality [@pone.0107145-Craig1]. Thus, a model can be envisioned by which thalamocortical pathways send a representation of homeostatic information to the posterior insula, thereby generating distinct interoceptive feelings that are projecting onto anterior insula to help in promoting emotional evaluation.

The anterior portion of the insula appears to have a more defined role in the interplay between high cognitive and emotional functions. In addition, compared to the left insula, the right region has a more prominent role in the exploration of the environment and spatial orientation. In particular, the right insula plays a fundamental role in spatial self-orientation and awareness of limb movements in space [@pone.0107145-Karnath2]--[@pone.0107145-Schneider1].

While many studies have dissected the role of the anterior insula, fewer reports have analyzed functioning of the posterior insula [@pone.0107145-Kriegeskorte1].

The right posterior insula appears to be more involved in monitoring the external environment as well as in response selection and action preparation. Several studies indicate that this region is an area of convergence for processing multimodal exteroceptive, interoceptive, vestibular, and auditory stimuli.

In our study, it is conceivable that the drug-dependent increase of FC that we observed between the right insula and putamen can promote enhanced monitoring of internal states aimed at motor planning. The overall nature of the insula-putamen connection lends some support to this hypothesis.

The putamen is a region involved in motivation and reward-related learning [@pone.0107145-Cromwell1], the area is in fact important to manage motor actions aimed at obtaining reward [@pone.0107145-Haruno1], [@pone.0107145-Knutson1].

The putamen and posterior insula are part of a network that controls decision making processes and impulsivity [@pone.0107145-Knutson2]--[@pone.0107145-McHugh1]. The dorsal-posterior insula also represents a key region for time encoding [@pone.0107145-Wittmann1].

The putamen activity helps in recognizing emotions and bodily states as well as motivation [@pone.0107145-Muranishi1], [@pone.0107145-Tomer1] and is thought to be driven by increased FC in the MCC, an area involved in goal-directed behavior. The ACC, a region that is functionally and structurally connected to the dorsal striatum, is involved in action planning and motivation. The cingulate cortex is important for social behavior and, supporting this concept, ACC lesions have been shown to lead to akinetic mutism and apathy [@pone.0107145-Damasio1], [@pone.0107145-Devinsky1].

The hippocampus and insula work together in visuospatial exploration [@pone.0107145-Ghaem1]. The parahippocampal regions are also involved in reward processing through activation of the ventral striatum [@pone.0107145-Adcock1]--[@pone.0107145-Lisman1]. Thus, one can speculate that modafinil may act in the early stages of cognitive processing that are associated with action preparation as well as motivation to act. In that respect, the right posterior insula can sustain motivation by working in synergy with the ACC and putamen along with the intervention of parahippocampal regions that are responsible for long-term storage of reward-related memories. Preclinical studies have clarified the role of insular orexin receptors in modulating motivation and lend support to our hypothesis as modafinil is a strong orexin receptor agonist [@pone.0107145-Hollander1].

Modafinil-dependent modifications of the right posterior-insula network activity may explain the pro-cognitive effects of the drug. Further research is warrant to evaluate the selective role of the posterior insula as important target for cognitive enhancing drugs.
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